Modafinil Paragraph IV ANDA Filing Entity

Modafinil Paragraph IV ANDA Filing Entity. Shall mean any entity that has notified or subsequently notifies Cephalon that it has filed an ANDA with a Paragraph IV certification concerning a product containing modafinil as an active ingredient for which PROVIGIL® (or any modafinil drug product that is the subject of Cephalon's NDA 20-717) is the reference listed drug.

Modafinil Paragraph IV ANDA Filing Entity. Any entity, other than Carlsbad or Watson, that has notified or subsequently notifies Cephalon that it has filed an ANDA with a Paragraph IV certification concerning a product containing modafinil as an API and for which PROVIGIL® is the reference listed drug.

Modafinil Paragraph IV ANDA Filing Entity. Shall mean any entity that has notified or subsequently notifies Cephalon that it has filed an ANDA with a Paragraph IV certification concerning a product containing modafinil as an active ingredient for which PROVIGIL® is the reference listed drug. **Portions of the Exhibit have been omitted and have been filed separately pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as... amended. 4 View More